Search filters

List of works by Francesco Zaja

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines

scientific article published on 28 February 2019

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

scientific article published on 29 May 2018

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.

scientific article

Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion

scientific article published on 01 March 2005

Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia

scientific article published on 01 August 1998

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

scientific article published on 20 June 2007

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

scientific article published on 6 October 2017

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

scientific article published in May 2013

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

scientific article published on 4 February 2015

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

scientific article

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.

scientific article published on 13 November 2013

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study

scientific article published on 22 April 2016

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

scientific article published on 15 February 2012

Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma

scientific article published on 09 March 2015

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

scientific article published on 3 October 2016

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

article

CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

scientific article

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

scientific article published on 16 July 2012

Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters.

scientific article published on 13 January 2012

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

scientific article published on 10 July 2019

Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.

scientific article

Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

scientific article

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

scientific article

Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia

scientific article published on 07 September 2018

Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia

scientific article published on 01 May 2006

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.

scientific article published on 19 November 2013

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

scientific article published on 05 July 2011

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.

scientific article

Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.

scientific article published on 26 April 2018

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

scientific article

HSV-1 cutaneous infection in a patient with Hodgkin's lymphoma treated with brentuximab vedotin.

scientific article published on 6 December 2013

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

scientific article published on 18 September 2009

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

scientific article published on 09 July 2018

Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia.

scientific article published on 7 August 2009

Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

scientific article

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

scientific article published on 07 January 2019

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma

scientific article published on 19 March 2019

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

scientific article published on 7 September 2016

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

scientific article published on 16 February 2016

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

scientific article published on 14 March 2019

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.

scientific article published on 16 February 2017

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.

scientific article published on 19 November 2014

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies

scientific article published on 20 January 2012

MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years

scientific article published on 14 March 2014

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

scientific article published on 01 May 2006

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients

scientific article published on 28 June 2018

Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study

scientific article published on 01 September 1996

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries

scientific article published on 16 January 2018

Management of immune thrombocytopenia in elderly patients

scientific article published on 29 September 2018

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.

scientific article published on 31 August 2013

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

scientific article published on 14 August 2015

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

scientific article published on 27 July 2017

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia

scientific article published on 26 May 2017

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

scientific article

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.

scientific article published on 22 September 2017

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

scientific article published on 13 July 2015

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.

scientific article published on 21 March 2017

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

scientific article

No evidences for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy

scientific article published on 01 May 2008

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

scientific article published on 01 March 2006

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.

scientific article published on 19 May 2017

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

scientific article published on 26 November 2003

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

scientific article published on 19 June 2015

Pharmacokinetic Behavior of Rituximab

scientific article published on 01 December 2005

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

scientific article

Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant.

scientific article

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)

scientific article published on 05 August 2019

Rituximab in a case of cold agglutinin disease

scientific article published on 01 October 2001

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

scientific article

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

scientific article published on 24 May 2019

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italia

scientific article published on 19 August 2013

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

scientific article published on 17 January 2006

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

scientific article published on 28 June 2017

Rituximab-responsive CIDP

scientific article published on 01 November 2004

Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.

scientific article published on 28 April 2017

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

scientific article published in July 2004

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

scientific article published on 12 January 2017

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study

scientific article published on 13 June 2018

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

scientific article published on 04 April 2018

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

scientific article

Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.

scientific article published on 18 August 2017

Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia

scientific article published on 03 October 2013

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

scientific article

Temozolomide as salvage treatment in primary brain lymphomas.

scientific article published on 27 February 2007

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

scientific article

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

scientific article

The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin’s lymphoma

scientific article published on December 1, 1997

Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study

scientific article

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.

scientific article

Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

scientific article published on 27 November 2017

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

scientific article

Trisomy 8 in chronic lymphocytic leukemia: a report of two cases

scientific article published on 01 June 2007

Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome

scientific article published on 27 June 2014

Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.

scientific article published on 20 August 2014